Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes

被引:12
作者
Dangi-Garimella, Surabhi [2 ]
Redig, Amanda J. [2 ]
Shields, Mario A. [2 ]
Siddiqui, Mohammed A. [2 ]
Munshi, Hidayatullah G. [1 ,2 ,3 ]
机构
[1] Northwestern Univ, Sch Med, Dept Med, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
VENTRAL BODY-WALL; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; TERMINAL DIFFERENTIATION; CALCIUM REGULATION; TISSUE INHIBITOR; CARCINOMA-CELLS; CANCER INVASION; TUMOR-GROWTH; EXPRESSION;
D O I
10.1074/jbc.M110.146019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Membrane type 1-matrix metalloproteinase (MT1-MMP, MMP14), which is associated with extracellular matrix (ECM) breakdown in squamous cell carcinoma (SCC), promotes tumor formation and epithelial-mesenchymal transition. However, in this report we demonstrate that MT1-MMP, by cleaving the underlying ECM, causes cellular aggregation of keratinocytes and SCC cells. Treatment with an MMP inhibitor abrogated MT1-MMP-induced phenotypic changes, but decreasing E-cadherin expression did not affect MT1-MMP-induced cellular aggregation. As ROCK1/2 can regulate cell-cell and cell-ECM interaction, we examined its role in mediating MT1-MMP-induced phenotypic changes. Blocking ROCK1/2 expression or activity abrogated the cellular aggregation resulting from MT1-MMP expression. Additionally, blocking Rho and nonmuscle myosin attenuated MT1-MMP-induced phenotypic changes. Moreover, SCC cells expressing only the catalytically active MT1-MMP protein demonstrated increased cellular aggregation and increased myosin II activity in vivo when injected subcutaneously into nude mice. Together, these results demonstrate that expression of MT1-MMP may be anti-tumorigenic in keratinocytes by promoting cellular aggregation.
引用
收藏
页码:28363 / 28372
页数:10
相关论文
共 78 条
[1]   BOTULINUM ADP-RIBOSYLTRANSFERASE C-3 - PURIFICATION OF THE ENZYME AND CHARACTERIZATION OF THE ADP-RIBOSYLATION REACTION IN PLATELET MEMBRANES [J].
AKTORIES, K ;
ROSENER, S ;
BLASCHKE, U ;
CHHATWAL, GS .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 172 (02) :445-450
[2]   Stromelysin-1 regulates adipogenesis during mammary gland involution [J].
Alexander, CM ;
Selvarajan, S ;
Mudgett, J ;
Werb, Z .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :693-703
[3]   Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-αv integrin regulates cross-talk between αvβ3 and α2β1 integrins in breast carcinoma cells [J].
Baciu, PC ;
Suleiman, EA ;
Deryugina, EI ;
Strongin, AY .
EXPERIMENTAL CELL RESEARCH, 2003, 291 (01) :167-175
[4]   Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].
Balbín, M ;
Fueyo, A ;
Tester, AM ;
Pendás, AM ;
Pitiot, AS ;
Astudillo, A ;
Overall, CM ;
Shapiro, SD ;
López-Otín, C .
NATURE GENETICS, 2003, 35 (03) :252-257
[5]   Membrane type 1-matrix metalloproteinase: Substrate diversity in pericellular proteolysis [J].
Barbolina, Maria V. ;
Stack, M. Sharon .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (01) :24-33
[6]   The small GTPases rho and rac are required for the establishment of cadherin-dependent cell-cell contacts [J].
Braga, VMM ;
Machesky, LM ;
Hall, A ;
Hotchin, NA .
JOURNAL OF CELL BIOLOGY, 1997, 137 (06) :1421-1431
[7]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[8]   Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion [J].
Calautti, E ;
Grossi, M ;
Mammucari, C ;
Aoyama, Y ;
Pirro, M ;
Ono, Y ;
Li, J ;
Dotto, GP .
JOURNAL OF CELL BIOLOGY, 2002, 156 (01) :137-148
[9]   Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. [J].
Cao, Jian ;
Chiarelli, Christian ;
Richman, Omer ;
Zarrabi, Kevin ;
Kozarekar, Pallavi ;
Zucker, Stanley .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (10) :6232-6240
[10]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392